Stock analysts at StockNews.com assumed coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a research report issued to clients and investors on Saturday. The firm set a "hold" rating on the stock.
Blonder Tongue Laboratories Stock Up 1.5 %
BDR opened at $0.31 on Friday. The firm has a fifty day simple moving average of $0.36. The stock has a market capitalization of $4.06 million, a price-to-earnings ratio of -4.36 and a beta of 0.55. Blonder Tongue Laboratories has a 12-month low of $0.28 and a 12-month high of $1.91. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.11 and a quick ratio of 0.38.
Get Blonder Tongue Laboratories alerts:Blonder Tongue Laboratories (NYSE:BDR – Get Rating) last released its earnings results on Friday, May 6th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $3.34 million during the quarter. Blonder Tongue Laboratories had a negative net margin of 4.14% and a negative return on equity of 18.69%.
About Blonder Tongue Laboratories
(Get Rating)Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders.
Read More
- Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
- Financial services firm Block stock has fallen (-59%) in 2022
- Hold Pfizer Today With Catalysts for Further Growth Tomorrow
- NVIDIA Stock is a Winding Up for a Record Setting Second Half
- Johnson & Johnson Continues to Prove its Value in a Volatile Year
- MarketBeat: Week in Review 7/11 – 7/15
Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.